ARKG vs. LBO ETF Comparison
Comparison of ARK Genomic Revolution Multi-Sector ETF (ARKG) to WHITEWOLF Publicly Listed Private Equity ETF (LBO)
ARKG
ARK Genomic Revolution Multi-Sector ETF
ARKG Description
Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.
Grade (RS Rating)
Last Trade
$23.22
Average Daily Volume
2,215,896
34
LBO
WHITEWOLF Publicly Listed Private Equity ETF
LBO Description
The fund is an actively managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in securities of U.S. publicly listed private equity companies. It defines "listed private equity companies" as Leverage Finance Providers and Buyout Firms, Sponsors, and Asset Managers (collectively, "Listed Private Equity Companies") that are listed and traded on a U.S. national securities exchange. The fund is non-diversified.Grade (RS Rating)
Last Trade
$34.00
Average Daily Volume
1,354
35
Performance
Period | ARKG | LBO |
---|---|---|
30 Days | -3.53% | 4.04% |
60 Days | -11.54% | 10.46% |
90 Days | -13.90% | 17.24% |
12 Months | -15.87% |
0 Overlapping Holdings
Symbol | Grade | Weight in ARKG | Weight in LBO | Overlap |
---|
ARKG Overweight 34 Positions Relative to LBO
Symbol | Grade | Weight | |
---|---|---|---|
TWST | F | 8.37% | |
RXRX | F | 7.42% | |
CRSP | D | 7.34% | |
ADPT | C | 5.03% | |
CDNA | D | 4.77% | |
VCYT | B | 4.51% | |
SDGR | C | 4.14% | |
BEAM | D | 4.01% | |
NTLA | F | 3.89% | |
IONS | F | 3.85% | |
NTRA | A | 3.82% | |
NRIX | C | 3.78% | |
TXG | F | 3.56% | |
GH | B | 3.49% | |
ARCT | F | 3.19% | |
PSNL | D | 2.7% | |
ABSI | F | 2.19% | |
PACB | F | 2.16% | |
BFLY | B | 1.71% | |
VEEV | C | 1.7% | |
AMGN | F | 1.68% | |
ACCD | D | 1.47% | |
VRTX | D | 1.29% | |
ILMN | C | 1.25% | |
CERS | D | 1.18% | |
INCY | C | 1.11% | |
REGN | F | 0.92% | |
PRME | F | 0.9% | |
CMPS | F | 0.75% | |
MASS | F | 0.69% | |
QSI | C | 0.68% | |
EXAS | D | 0.65% | |
RPTX | F | 0.64% | |
MRNA | F | 0.01% |
ARKG Underweight 35 Positions Relative to LBO
Symbol | Grade | Weight | |
---|---|---|---|
KKR | A | -8.25% | |
ARCC | A | -6.95% | |
FSK | A | -6.75% | |
TPG | A | -6.64% | |
OWL | A | -6.37% | |
BX | A | -6.26% | |
APO | B | -6.11% | |
BXSL | A | -6.1% | |
ARES | A | -5.23% | |
CG | B | -5.12% | |
HTGC | D | -4.76% | |
HLNE | B | -3.14% | |
GBDC | D | -3.07% | |
PSEC | D | -2.42% | |
CSWC | D | -2.31% | |
GSBD | F | -2.08% | |
BBDC | A | -1.83% | |
BCSF | C | -1.67% | |
TRIN | A | -1.43% | |
NMFC | D | -1.33% | |
STEP | C | -1.21% | |
PFLT | D | -1.14% | |
CODI | B | -1.09% | |
TCPC | C | -1.07% | |
CGBD | C | -0.82% | |
CION | C | -0.74% | |
TSLX | C | -0.44% | |
GCMG | B | -0.22% | |
SCM | B | -0.2% | |
PNNT | C | -0.2% | |
FDUS | A | -0.16% | |
GAIN | B | -0.14% | |
SAR | A | -0.14% | |
PX | A | -0.14% | |
TPVG | B | -0.14% |
ARKG: Top Represented Industries & Keywords
LBO: Top Represented Industries & Keywords